Pacira Pharmaceuticals, Inc. (PCRX) Stock
Fundamentals
Latest news
About Pacira Pharmaceuticals, Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Frank D. Lee | CEO & Director | 1968 |
| Mr. Shawn M. Cross | Chief Financial Officer | 1968 |
| Ms. Kristen Williams Esq., J.D. | Chief Administrative Officer & Secretary | 1974 |
| Dr. Jonathan Slonin M.D. | Chief Medical Officer | 1975 |
| Mr. Brendan P. Teehan | Chief Commercial Officer | 1969 |
| Ms. Lauren Bullaro Riker | Principal Accounting Officer & Senior VP of Finance | 1979 |
| Ms. Susan Mesco | Head of Investor Relations | — |
| Mr. Anthony Molloy III, Esq. | Chief Legal & Compliance Officer | 1974 |
| Mr. Christopher C. Young | Chief Manufacturing Officer | 1972 |
| Ms. Krys Corbett Esq. | Chief Business Officer | — |



